Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
24,447 total articles
Inspired Entertainment announced the launch of its NBA Re-Play Virtual Sports game in Turkey, distributed via Sisal Şans and several Electronic Platform Dealers. Featuring all 30 NBA teams and licensed by the NBA and NBPA, the fast-paced virtual basketball game offers a new engaging betting experience to Turkish fans and strengthens Inspired's glob…
CSX Corp., a leading transportation company specializing in rail and intermodal services, announced it will release its second quarter financial results after market close on July 22, 2026, followed by a conference call and live webcast hosted by management.
Micron Technology has entered a strategic partnership with AI company Anthropic to collaborate on memory and storage technology tailored for frontier AI models, secure supply agreements, adopt Anthropic's Claude AI models within Micron, and make a strategic investment in Anthropic's Series H funding round. This collaboration aims to innovate and sc…
Syntec Optics, traded on Nasdaq under the ticker OPTX, announced it has received nearly $4 million in new U.S. life sciences purchase orders, adding to previous $4.6 million in biomedical optics orders. The company's high-precision optical products support a broad range of applications in surgical robotics, DNA sequencing, biomedical visualization,…
InterCure Ltd., listed on NASDAQ and TASE, announced a private placement financing raising NIS 22 million (~US$7.4 million) with potential to increase to NIS 54 million (~US$18.6 million). Key investors include CEO Alexander Rabinovich and leading pharma-focused hedge funds such as Bennu Pharma Fund. The funds will support expansion of InterCure's …
Enlivex Ltd. updates its treasury portfolio, reporting holdings of approximately 79.6 billion RAIN tokens valued at about $1.14 billion as of June 20, 2026. This substantial asset contributes to a Treasury NAV per Share of $4.671, reflecting strong market valuation of its blockchain-based prediction markets treasury strategy alongside its clinical-…
AIM ImmunoTech announced it will present at the Webull Corporate Connect Webinar Series on June 24, 2026. The company focuses on developing Ampligen, a drug aimed at treating late-stage pancreatic cancer. Webull is a global digital investment platform with over 27 million users.
SeaStar Medical Holding Corporation announced its CEO will present at the upcoming Virtual Investor Summit, discussing its innovative FDA-approved and breakthrough-designated therapies for acute kidney injury (AKI) in critically ill patients. The company is advancing clinical trials for its Selective Cytopheretic Device (SCD) therapy targeting urge…
SEALSQ Corp announces its QS7001 Post-Quantum Secure Element aligns with a new French regulatory requirement mandating post-quantum encryption for critical infrastructure. With the ANSSI mandate effective from 2027 and full adoption by 2030, SEALSQ's NIST-validated QS7001 hardware product is primed for rapid market adoption. The company is experien…
Patriot Bank, a subsidiary of Patriot National Bancorp, is launching a new flagship branch in Palm Beach, Florida, aiming to serve high-net-worth individuals and businesses with personalized banking and lending solutions. Led by experienced market executives Jamie Bruneau and James Ford, the expansion enhances the bank's presence in key wealth cent…
NeoVolta Inc. announced that its Pendergrass, Georgia battery manufacturing facility complies with Foreign Entity of Concern (FEOC) requirements, making it eligible for IRS advanced manufacturing and investment tax credits. Site Acceptance Testing is scheduled to complete by August 2026, with production ramp-up expected in Q3 2026. This compliance …
Achieve Life Sciences received a Complete Response Letter from the FDA regarding its NDA for cytisinicline, citing deficiencies at a previous third-party manufacturing facility and incomplete product labeling. The FDA found no clinical efficacy or safety issues. The company has switched manufacturing to Adare Pharma and plans to resubmit the NDA in…
Eos Energy Enterprises announced that its Z3 battery modules passed independent destructive fire testing with no thermal runaway, sustained fire, or propagation, meeting new NFPA 855 safety standards for large-scale energy storage. The company also received ISO 14001 certification, underscoring its commitment to environmental management. These resu…
FibroBiologics announced that the USPTO issued a Notice of Allowance for their patent application covering methods of treating wounds using topical 3D spheroid fibroblasts and fibroblast-derived materials. This patent supports their lead clinical program, CYWC628, being evaluated for diabetic foot ulcers, a challenging chronic wound.
Entera Bio announced positive feedback from the FDA on its Phase 3 study protocol for EB613, the first oral anabolic tablet for treating osteoporosis in postmenopausal women. The Phase 3 trial, planned to start in late 2026 with topline data expected in late 2028, will evaluate EB613's efficacy in improving total hip bone mineral density. The NDA s…
NewGenIVF Group Limited has issued 3,666,667 new shares to acquire a 10% stake in AI-focused K25.ai, raising its total shares to over 10 million and increasing market capitalization to $7.6 million. This capital boost supports NewGen's strategic pivot towards AI, digital platforms, and prediction markets in APAC, backed by a $10 million investment …
Vivos Therapeutics, Inc., a NASDAQ-listed medical device company specializing in sleep apnea treatments, has extended its financing agreement timeframe with Streeterville Capital to August 31, 2026. This extension allows the company more time to raise equity in an organized manner and for Streeterville to convert up to $4.5 million of outstanding d…
Kingstone Companies, Inc. announced the appointment of Sylvie Widjaja as Vice President, California Business Leader, to spearhead the company's entry into the California homeowners insurance market on an excess and surplus lines basis. Widjaja brings over 20 years of California market experience, including leadership roles at Mercury Insurance Grou…
Saratoga Investment Corp., a business development company specializing in customized financing for U.S. middle-market businesses, will release its fiscal first quarter 2027 financial results on July 7, 2026, with a follow-up conference call scheduled for July 8, 2026. The company focuses on senior and unitranche leveraged loans, mezzanine debt, and…
Playboy, Inc. (NASDAQ: PLBY) has entered a definitive agreement to repurchase 16.6 million shares held by Fortress Investment Group at $1.05 per share, a 28% discount to market value, totaling $17.4 million. The deal covers nearly 15% of outstanding shares and is immediately accretive to earnings per share. Part of the purchase price has been paid …
Atlantic International Corp. announced a record first quarter 2026 revenue of $249.9 million, representing a 143% increase year-over-year, driven by the acquisition and integration of Circle8 Group. The acquisition expanded Atlantic's geographic reach and scale, establishing it as a major transatlantic workforce solutions platform with combined ann…
Nexentis Technologies' wholly owned subsidiary, MitoCareX Bio, has entered a strategic partnership with AI research lab Boltz to combine their proprietary MITOLINE® structural modeling with Boltz's biomolecular AI models. This collaboration aims to accelerate the discovery of novel small-molecule therapies targeting solute carrier (SLC) proteins re…
Clearmind Medicine has announced the completion of treatment for all participants in the initial phase (Part A) of its ongoing FDA-regulated Phase I/II clinical trial evaluating CMND-100, a novel therapeutic for Alcohol Use Disorder. The company is analyzing data and plans to proceed to the next stage of clinical development, advancing its non-hall…
Verrica Pharmaceuticals announced dosing of the first U.S. patient in the COVE-3 Phase 3 clinical trial evaluating YCANTH® (VP-102) for common warts. With a global Phase 3 program ongoing, including its Japanese partner Torii Pharmaceutical, the company targets a significant market with no current FDA-approved treatments. Positive Phase 2 results a…
Outdoor Holding Company, operator of GunBroker.com, reported a 10.1% revenue increase and significant reduction in operating losses for Q4 and fiscal year 2026, driven by cost reductions, settlement of legacy legal matters, and platform investments including AI enhancements. Adjusted EBITDA more than doubled year-over-year, with improved gross marg…
